MarketResearchNest.com adds “Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2017-2021” new reports to its research database. The report spread across 88 pages with tables and figures in it.
The research analysts forecast the global hematopoietic stem cells transplantation (HSCT) market to grow at a CAGR of 5.75% during the period 2017-2021.
HSCT is the most widely used stem-cell therapy, where blood from umbilical cord is used. Research is being undertaken to discover various sources (such as cord blood cells, bone marrow, and peripheral blood cells) of hematopoietic stem cells to treat various disorders like hematological malignancies, blood related disorders (leukemia and lymphoma), neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.
Stem-cell therapy has become controversial after developments in isolating and culturing of embryonic stem cells. Somatic cell nuclear transfer is the technique used in embryonic stem cell research to create stem cells and induced pluripotent stem cells. This controversy is related to abortion policies and human cloning. However, the changing regulatory landscape in countries like the US and Japan may help to accelerate the clinical trials.
Get more details about report at https://www.marketresearchnest.com/global-hematopoietic-stem-cells-transplantation-hsct-market-2017-2021.html .
Technavio recognizes the following companies as the key players in the global hematopoietic stem cells transplantation (HSCT) market: AllCells, Lonza, Merck, and Sanofi
Other Prominent Vendors in the market are: Athersys, Beike Biotechnology, BioTime, bluebird bio, Caladrius, Cellular Biomedicine Group, Cellular Dynamics International (a subsidiary of Fujifilm), Cesca Therapeutics, CHA Biotech, CORESTEM, Gamida Cell, Global Stem Cells Group, Hemostemix, Histocell, Mesoblast, TiGenix, and Translational Biosciences (a subsidiary of Medistem Panama).
The latest trend gaining momentum in the market is Growing demand for personalized medicine. Personalized medicine can offer treatments based on the patient’s characteristics, needs, and preferences. Therefore, research organizations are extensively exploring ways to develop personalized treatments by using mesenchymal stem cells owing to its higher benefits. Their benefits include low risk of immune rejection, no requirement of embryonic stem cell, limited need for anti-rejection drugs, low risk of graft rejection, and less chance of developing GvHD.
Order a Purchase Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=264859 . (This is premium report, Single User License – USD 3500 and Corporate User License – USD 6000)
According to the report, one of the major drivers for this market is Rising number of HSCT. Owing to the efficacy of HSCT, their demand is ever growing for treating leukemia, lymphoma, immune-deficiency illnesses, hemoglobinopathies, congenital metabolic defects, and myelodysplastic and myeloproliferative syndromes. Further, over the period of time, it has been observed that the allogenic HSCT outweighs the autologous transplants despite allogenic being more susceptible to GvHD.
Further, the report states that one of the major factors hindering the growth of this market is High cost of HSCT. The number of HSCT transplant is expected to increase due to continuous advancements in the transplantation technology, emergence of new indications, supportive care practices, and availability of alternative graft source. In 2009, HSCT was one of the top ten procedures associated with increased hospital cost. The overall cost associated with HSCT has shown 85% increase between 2004 and 2007, which is from $694 million to $1.3 billion.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Inquire before buying this report at https://www.marketresearchnest.com/enquirybuy.php?reportid=264859 .
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.
Mr. Jeet Jain
+1-240-284-8070 / +44-20-3290-4151